Radiosensitisation of bladder cancer cells by panobinostat is modulated by Ku80 expression.

Radiosensitisation of bladder cancer cells by panobinostat is modulated by Ku80 expression.

Pokaż inne wersje (1)

BACKGROUND AND PURPOSE: In muscle-invasive bladder cancer there is an urgent need to identify relatively non-toxic radiosensitising agents for use in elderly patients. Histone deacetylase inhibitors radiosensitise tumour cells but not normal cells in vitro and variously downregulate DNA damage signa...

Szczegółowa specyfikacja

Opis bibliograficzny
Główni autorzy:	Groselj, B, Kerr, M, Kiltie, A
Format:	Journal article
Język:	English
Wydane:	2013

Podobne zapisy

Radiosensitisation of bladder cancer cells by panobinostat is modulated by Ku80 expression
od: Groselj, B, i wsp.
Wydane: (2013)

The histone deacetylase inhibitor panobinostat as a radiosensitiser in bladder cancer
od: Groselj, B
Wydane: (2014)

The HDAC Inhibitor Panobinostat Promotes Expression of Delta 133p53 Variants in TP53 Wild-type Bladder Cancer Cells
od: Groselj, B, i wsp.
Wydane: (2012)

Differential Roles of Ku70 and Ku80 in the MMEJ Phenotype
od: Brideau, C, i wsp.
Wydane: (2012)

Histone deacetylase inhibitors as radiosensitisers: Effects on DNA damage signalling and repair
od: Groselj, B, i wsp.
Wydane: (2013)

Histone deacetylase inhibitors as radiosensitisers: effects on DNA damage signalling and repair.
od: Groselj, B, i wsp.
Wydane: (2013)

Radiosensitisation in vivo by histone deacetylase inhibition with no increase in early normal tissue radiation toxicity
od: Groselj, B, i wsp.
Wydane: (2017)

The histone deacetylase inhibitor romidepsin spares normal tissues while acting as an effective radiosensitiser in bladder tumours in vivo
od: Paillas, S, i wsp.
Wydane: (2020)

Metformin is a metabolic modulator and radiosensitiser in rectal cancer
od: Croí E. Buckley, i wsp.
Wydane: (2023-08-01)

SPRTN protease-cleaved MRE11 decreases DNA repair and radiosensitises cancer cells
od: Na, J, i wsp.
Wydane: (2021)

Dietary fibre manipulation as a potential endogenous mechanism of radiosensitisation in bladder cancer
od: Then, CK
Wydane: (2022)

SPRTN protease-cleaved MRE11 decreases DNA repair and radiosensitises cancer cells
od: Juri Na, i wsp.
Wydane: (2021-02-01)

Association of Bacteroides acidifaciens relative abundance with high-fibre diet-associated radiosensitisation
od: Then, CK, i wsp.
Wydane: (2020)

Association of Bacteroides acidifaciens relative abundance with high-fibre diet-associated radiosensitisation
od: Chee Kin Then, i wsp.
Wydane: (2020-08-01)

Gemcitabine as a Chemoradiosensitiser in Bladder Cancer
od: Kerr, M, i wsp.
Wydane: (2012)

Imatinib radiosensitizes bladder cancer by targeting homologous recombination.
od: Qiao, B, i wsp.
Wydane: (2013)

Metformin Augments Panobinostat's Anti-Bladder Cancer Activity by Activating AMP-Activated Protein Kinase
od: Kazuki Okubo, i wsp.
Wydane: (2019-04-01)

Predictive Biomarkers for Gemcitabine as a Chemoradiosensitizer in Bladder Cancer
od: Kerr, M, i wsp.
Wydane: (2012)

Identification of novel strategies to radiosensitise tumour cells
od: Anbalagan, S
Wydane: (2014)

Author Correction to: Association of Bacteroides acidifaciens relative abundance with high-fibre diet-associated radiosensitisation
od: Chee Kin Then, i wsp.
Wydane: (2021-07-01)

Ritonavir, a potent inhibitor of CYP3A4, enhances the anticancer effects of panobinostat in bladder cancer cells
od: A. Sato, i wsp.
Wydane: (2020-07-01)

Modulating tumour metabolism enhances gold nanoparticle radiosensitisation in HPV-negative head and neck cancer
od: Jie Feng, i wsp.
Wydane: (2023-04-01)

Integrated analysis reveals FOXA1 and Ku70/Ku80 as targets of ivermectin in prostate cancer
od: Shidong Lv, i wsp.
Wydane: (2022-09-01)

Hyperthermia Induces Apoptosis of 786-O Cells through Suppressing Ku80 Expression.
od: Defeng Qi, i wsp.
Wydane: (2015-01-01)

Discovery and investigation of novel radiosensitising genes
od: Tiwana, G
Wydane: (2015)

Repurposing radiosensitising medicines for radiotherapy: an overview
od: Geoff S Higgins, i wsp.
Wydane: (2024-07-01)

E3 ligase cIAP2 mediates downregulation of MRE11 and radiosensitization in response to HDAC inhibition in bladder cancer
od: Nicholson, J, i wsp.
Wydane: (2017)

Ku80 is highly expressed in lung adenocarcinoma and promotes cisplatin resistance
od: Ma Qingshan, i wsp.
Wydane: (2012-11-01)

Hydralazine and Panobinostat Attenuate Malignant Properties of Prostate Cancer Cell Lines
od: Mariana Brütt Pacheco, i wsp.
Wydane: (2021-07-01)

Nuclear expression of Ku70/80 is associated with CHEK2 germline mutations in breast cancer
od: Rosik Jakub, i wsp.
Wydane: (2023-07-01)

Design, Synthesis and Anticancer Evaluation of Nitroimidazole Radiosensitisers
od: Lydia P. Liew, i wsp.
Wydane: (2023-05-01)

Identification of anticancer drugs to radiosensitise BRAFwild-type and mutant colorectal cancer
od: Carter, R, i wsp.
Wydane: (2019)

Higher Expression of Ku80 and Ku70 Indicates Hotter Tumor Immune Microenvironment in Hepatocellular Carcinoma and Better CTL-Centered Immunotherapy
od: Yang L, i wsp.
Wydane: (2024-11-01)

Internalising radioimmunoconjugates to target KRas cancer cells for simultaneous radio-ligand therapy and radiosensitisation
od: Lourenço, J
Wydane: (2024)

Comparative study of the radiosensitising and cell cycle effects of vinflunine and vinorelbine, <it>in vitro</it>
od: Pattyn Greet GO, i wsp.
Wydane: (2008-02-01)

Anti-tumour and radiosensitising effects of PARP inhibitor on cervical cancer xenografts
od: Qin Xue, i wsp.
Wydane: (2023-12-01)

Radiosensitising effect of electrochemotherapy with bleomycin in LPB sarcoma cells and tumors in mice
od: Sentjurc Marjeta, i wsp.
Wydane: (2005-09-01)

Inhibition of glycolysis and mitochondrial respiration promotes radiosensitisation of neuroblastoma and glioma cells
od: Donna L. Nile, i wsp.
Wydane: (2021-05-01)

The histone deacetylase inhibitor LBH589 (panobinostat) modulates the crosstalk of lymphocytes with Hodgkin lymphoma cell lines.
od: Jan M Klein, i wsp.
Wydane: (2013-01-01)

Synergy of yttrium-90 microspheres therapy with radiosensitising chemotherapy
od: Sharma, R
Wydane: (2012)